Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments
Digital Health Global
SEPTEMBER 27, 2023
With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.” Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics, and digital health companies, as well as early-stage VC funds.
88 
Let's personalize your content